nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—CYP2B6—Diphenhydramine—atopic dermatitis	0.0927	0.192	CbGbCtD
Tramadol—CYP3A4—Pimecrolimus—atopic dermatitis	0.0654	0.135	CbGbCtD
Tramadol—CYP2D6—Loratadine—atopic dermatitis	0.0448	0.0926	CbGbCtD
Tramadol—CYP2D6—Diphenhydramine—atopic dermatitis	0.0448	0.0926	CbGbCtD
Tramadol—CYP3A4—Tacrolimus—atopic dermatitis	0.0389	0.0805	CbGbCtD
Tramadol—CYP2B6—Dexamethasone—atopic dermatitis	0.0321	0.0663	CbGbCtD
Tramadol—CYP3A4—Loratadine—atopic dermatitis	0.0285	0.0589	CbGbCtD
Tramadol—CYP3A4—Methylprednisolone—atopic dermatitis	0.026	0.0539	CbGbCtD
Tramadol—CYP3A4—Triamcinolone—atopic dermatitis	0.0197	0.0408	CbGbCtD
Tramadol—CYP3A4—Betamethasone—atopic dermatitis	0.0169	0.035	CbGbCtD
Tramadol—CYP3A4—Prednisolone—atopic dermatitis	0.0167	0.0346	CbGbCtD
Tramadol—CYP3A4—Hydrocortisone—atopic dermatitis	0.0158	0.0328	CbGbCtD
Tramadol—CYP3A4—Prednisone—atopic dermatitis	0.0158	0.0326	CbGbCtD
Tramadol—CYP2D6—Dexamethasone—atopic dermatitis	0.0155	0.032	CbGbCtD
Tramadol—CYP3A4—Dexamethasone—atopic dermatitis	0.00985	0.0204	CbGbCtD
Tramadol—Cough—Triamcinolone—atopic dermatitis	0.000102	0.00023	CcSEcCtD
Tramadol—Headache—Tacrolimus—atopic dermatitis	0.000101	0.000229	CcSEcCtD
Tramadol—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000101	0.000229	CcSEcCtD
Tramadol—Convulsion—Triamcinolone—atopic dermatitis	0.000101	0.000228	CcSEcCtD
Tramadol—Tachycardia—Prednisolone—atopic dermatitis	0.000101	0.000228	CcSEcCtD
Tramadol—Convulsion—Methylprednisolone—atopic dermatitis	0.000101	0.000228	CcSEcCtD
Tramadol—Hypertension—Triamcinolone—atopic dermatitis	0.000101	0.000228	CcSEcCtD
Tramadol—Hypertension—Methylprednisolone—atopic dermatitis	0.0001	0.000227	CcSEcCtD
Tramadol—Infection—Hydrocortisone—atopic dermatitis	0.0001	0.000227	CcSEcCtD
Tramadol—Hyperhidrosis—Prednisolone—atopic dermatitis	9.99e-05	0.000226	CcSEcCtD
Tramadol—Shock—Hydrocortisone—atopic dermatitis	9.93e-05	0.000225	CcSEcCtD
Tramadol—Myalgia—Triamcinolone—atopic dermatitis	9.92e-05	0.000224	CcSEcCtD
Tramadol—Nervous system disorder—Hydrocortisone—atopic dermatitis	9.9e-05	0.000224	CcSEcCtD
Tramadol—Myalgia—Methylprednisolone—atopic dermatitis	9.89e-05	0.000224	CcSEcCtD
Tramadol—Arthralgia—Methylprednisolone—atopic dermatitis	9.89e-05	0.000224	CcSEcCtD
Tramadol—Eye disorder—Prednisone—atopic dermatitis	9.88e-05	0.000224	CcSEcCtD
Tramadol—Anxiety—Methylprednisolone—atopic dermatitis	9.86e-05	0.000223	CcSEcCtD
Tramadol—Tachycardia—Hydrocortisone—atopic dermatitis	9.85e-05	0.000223	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	9.83e-05	0.000222	CcSEcCtD
Tramadol—Flushing—Prednisone—atopic dermatitis	9.81e-05	0.000222	CcSEcCtD
Tramadol—Skin disorder—Hydrocortisone—atopic dermatitis	9.81e-05	0.000222	CcSEcCtD
Tramadol—Ill-defined disorder—Betamethasone—atopic dermatitis	9.81e-05	0.000222	CcSEcCtD
Tramadol—Ill-defined disorder—Dexamethasone—atopic dermatitis	9.81e-05	0.000222	CcSEcCtD
Tramadol—Discomfort—Triamcinolone—atopic dermatitis	9.8e-05	0.000222	CcSEcCtD
Tramadol—Discomfort—Methylprednisolone—atopic dermatitis	9.78e-05	0.000221	CcSEcCtD
Tramadol—Hyperhidrosis—Hydrocortisone—atopic dermatitis	9.76e-05	0.000221	CcSEcCtD
Tramadol—Dry mouth—Triamcinolone—atopic dermatitis	9.7e-05	0.00022	CcSEcCtD
Tramadol—Angioedema—Dexamethasone—atopic dermatitis	9.66e-05	0.000219	CcSEcCtD
Tramadol—Angioedema—Betamethasone—atopic dermatitis	9.66e-05	0.000219	CcSEcCtD
Tramadol—Anorexia—Hydrocortisone—atopic dermatitis	9.62e-05	0.000218	CcSEcCtD
Tramadol—Nausea—Tacrolimus—atopic dermatitis	9.61e-05	0.000218	CcSEcCtD
Tramadol—Angiopathy—Prednisone—atopic dermatitis	9.59e-05	0.000217	CcSEcCtD
Tramadol—Confusional state—Methylprednisolone—atopic dermatitis	9.56e-05	0.000216	CcSEcCtD
Tramadol—Immune system disorder—Prednisone—atopic dermatitis	9.55e-05	0.000216	CcSEcCtD
Tramadol—Malaise—Dexamethasone—atopic dermatitis	9.53e-05	0.000216	CcSEcCtD
Tramadol—Malaise—Betamethasone—atopic dermatitis	9.53e-05	0.000216	CcSEcCtD
Tramadol—Anaphylactic shock—Triamcinolone—atopic dermatitis	9.51e-05	0.000215	CcSEcCtD
Tramadol—Vertigo—Betamethasone—atopic dermatitis	9.49e-05	0.000215	CcSEcCtD
Tramadol—Vertigo—Dexamethasone—atopic dermatitis	9.49e-05	0.000215	CcSEcCtD
Tramadol—Anaphylactic shock—Methylprednisolone—atopic dermatitis	9.48e-05	0.000215	CcSEcCtD
Tramadol—Syncope—Dexamethasone—atopic dermatitis	9.48e-05	0.000215	CcSEcCtD
Tramadol—Syncope—Betamethasone—atopic dermatitis	9.48e-05	0.000215	CcSEcCtD
Tramadol—Arrhythmia—Prednisone—atopic dermatitis	9.44e-05	0.000214	CcSEcCtD
Tramadol—Infection—Triamcinolone—atopic dermatitis	9.44e-05	0.000214	CcSEcCtD
Tramadol—Hypotension—Hydrocortisone—atopic dermatitis	9.43e-05	0.000214	CcSEcCtD
Tramadol—Infection—Methylprednisolone—atopic dermatitis	9.42e-05	0.000213	CcSEcCtD
Tramadol—Shock—Triamcinolone—atopic dermatitis	9.35e-05	0.000212	CcSEcCtD
Tramadol—Insomnia—Prednisolone—atopic dermatitis	9.35e-05	0.000212	CcSEcCtD
Tramadol—Shock—Methylprednisolone—atopic dermatitis	9.33e-05	0.000211	CcSEcCtD
Tramadol—Nervous system disorder—Methylprednisolone—atopic dermatitis	9.3e-05	0.000211	CcSEcCtD
Tramadol—Loss of consciousness—Dexamethasone—atopic dermatitis	9.29e-05	0.00021	CcSEcCtD
Tramadol—Loss of consciousness—Betamethasone—atopic dermatitis	9.29e-05	0.00021	CcSEcCtD
Tramadol—Paraesthesia—Prednisolone—atopic dermatitis	9.28e-05	0.00021	CcSEcCtD
Tramadol—Tachycardia—Triamcinolone—atopic dermatitis	9.28e-05	0.00021	CcSEcCtD
Tramadol—Mental disorder—Prednisone—atopic dermatitis	9.26e-05	0.00021	CcSEcCtD
Tramadol—Tachycardia—Methylprednisolone—atopic dermatitis	9.26e-05	0.00021	CcSEcCtD
Tramadol—Skin disorder—Methylprednisolone—atopic dermatitis	9.21e-05	0.000209	CcSEcCtD
Tramadol—Malnutrition—Prednisone—atopic dermatitis	9.2e-05	0.000208	CcSEcCtD
Tramadol—Erythema—Prednisone—atopic dermatitis	9.2e-05	0.000208	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	9.2e-05	0.000208	CcSEcCtD
Tramadol—Hyperhidrosis—Triamcinolone—atopic dermatitis	9.19e-05	0.000208	CcSEcCtD
Tramadol—Hyperhidrosis—Methylprednisolone—atopic dermatitis	9.17e-05	0.000208	CcSEcCtD
Tramadol—Convulsion—Dexamethasone—atopic dermatitis	9.16e-05	0.000207	CcSEcCtD
Tramadol—Convulsion—Betamethasone—atopic dermatitis	9.16e-05	0.000207	CcSEcCtD
Tramadol—Insomnia—Hydrocortisone—atopic dermatitis	9.13e-05	0.000207	CcSEcCtD
Tramadol—Hypertension—Dexamethasone—atopic dermatitis	9.12e-05	0.000207	CcSEcCtD
Tramadol—Hypertension—Betamethasone—atopic dermatitis	9.12e-05	0.000207	CcSEcCtD
Tramadol—Paraesthesia—Hydrocortisone—atopic dermatitis	9.07e-05	0.000205	CcSEcCtD
Tramadol—Myalgia—Dexamethasone—atopic dermatitis	9e-05	0.000204	CcSEcCtD
Tramadol—Myalgia—Betamethasone—atopic dermatitis	9e-05	0.000204	CcSEcCtD
Tramadol—Anxiety—Dexamethasone—atopic dermatitis	8.97e-05	0.000203	CcSEcCtD
Tramadol—Anxiety—Betamethasone—atopic dermatitis	8.97e-05	0.000203	CcSEcCtD
Tramadol—CHRM3—GPCR ligand binding—CXCR3—atopic dermatitis	8.94e-05	0.00119	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CCL27—atopic dermatitis	8.9e-05	0.00119	CbGpPWpGaD
Tramadol—Discomfort—Dexamethasone—atopic dermatitis	8.89e-05	0.000201	CcSEcCtD
Tramadol—Discomfort—Betamethasone—atopic dermatitis	8.89e-05	0.000201	CcSEcCtD
Tramadol—Dyspepsia—Hydrocortisone—atopic dermatitis	8.89e-05	0.000201	CcSEcCtD
Tramadol—Hypotension—Methylprednisolone—atopic dermatitis	8.86e-05	0.000201	CcSEcCtD
Tramadol—Pain—Prednisolone—atopic dermatitis	8.84e-05	0.0002	CcSEcCtD
Tramadol—Decreased appetite—Hydrocortisone—atopic dermatitis	8.78e-05	0.000199	CcSEcCtD
Tramadol—OPRD1—GPCR downstream signaling—IL5—atopic dermatitis	8.74e-05	0.00117	CbGpPWpGaD
Tramadol—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	8.72e-05	0.000197	CcSEcCtD
Tramadol—OPRM1—Signaling by GPCR—CCL11—atopic dermatitis	8.7e-05	0.00116	CbGpPWpGaD
Tramadol—Fatigue—Hydrocortisone—atopic dermatitis	8.7e-05	0.000197	CcSEcCtD
Tramadol—Vision blurred—Prednisone—atopic dermatitis	8.67e-05	0.000196	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	8.66e-05	0.000196	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	8.64e-05	0.000196	CcSEcCtD
Tramadol—Pain—Hydrocortisone—atopic dermatitis	8.63e-05	0.000195	CcSEcCtD
Tramadol—Anaphylactic shock—Betamethasone—atopic dermatitis	8.63e-05	0.000195	CcSEcCtD
Tramadol—Anaphylactic shock—Dexamethasone—atopic dermatitis	8.63e-05	0.000195	CcSEcCtD
Tramadol—OPRD1—Signaling Pathways—CCL17—atopic dermatitis	8.61e-05	0.00115	CbGpPWpGaD
Tramadol—Insomnia—Triamcinolone—atopic dermatitis	8.6e-05	0.000195	CcSEcCtD
Tramadol—CHRM3—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	8.58e-05	0.00114	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—FCER2—atopic dermatitis	8.58e-05	0.00114	CbGpPWpGaD
Tramadol—Insomnia—Methylprednisolone—atopic dermatitis	8.58e-05	0.000194	CcSEcCtD
Tramadol—Infection—Dexamethasone—atopic dermatitis	8.57e-05	0.000194	CcSEcCtD
Tramadol—Infection—Betamethasone—atopic dermatitis	8.57e-05	0.000194	CcSEcCtD
Tramadol—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	8.54e-05	0.00114	CbGpPWpGaD
Tramadol—Ill-defined disorder—Prednisone—atopic dermatitis	8.54e-05	0.000193	CcSEcCtD
Tramadol—Paraesthesia—Triamcinolone—atopic dermatitis	8.54e-05	0.000193	CcSEcCtD
Tramadol—OPRD1—Signaling by GPCR—TAC1—atopic dermatitis	8.53e-05	0.00114	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—NPS—atopic dermatitis	8.53e-05	0.00114	CbGpPWpGaD
Tramadol—Feeling abnormal—Prednisolone—atopic dermatitis	8.52e-05	0.000193	CcSEcCtD
Tramadol—Paraesthesia—Methylprednisolone—atopic dermatitis	8.52e-05	0.000193	CcSEcCtD
Tramadol—Anaemia—Prednisone—atopic dermatitis	8.51e-05	0.000193	CcSEcCtD
Tramadol—Shock—Betamethasone—atopic dermatitis	8.49e-05	0.000192	CcSEcCtD
Tramadol—Shock—Dexamethasone—atopic dermatitis	8.49e-05	0.000192	CcSEcCtD
Tramadol—Dyspnoea—Triamcinolone—atopic dermatitis	8.47e-05	0.000192	CcSEcCtD
Tramadol—Nervous system disorder—Dexamethasone—atopic dermatitis	8.46e-05	0.000191	CcSEcCtD
Tramadol—Nervous system disorder—Betamethasone—atopic dermatitis	8.46e-05	0.000191	CcSEcCtD
Tramadol—Agitation—Prednisone—atopic dermatitis	8.46e-05	0.000191	CcSEcCtD
Tramadol—Thrombocytopenia—Dexamethasone—atopic dermatitis	8.44e-05	0.000191	CcSEcCtD
Tramadol—Thrombocytopenia—Betamethasone—atopic dermatitis	8.44e-05	0.000191	CcSEcCtD
Tramadol—Tachycardia—Betamethasone—atopic dermatitis	8.42e-05	0.000191	CcSEcCtD
Tramadol—Tachycardia—Dexamethasone—atopic dermatitis	8.42e-05	0.000191	CcSEcCtD
Tramadol—OPRK1—Signaling Pathways—CCL27—atopic dermatitis	8.41e-05	0.00112	CbGpPWpGaD
Tramadol—Angioedema—Prednisone—atopic dermatitis	8.41e-05	0.00019	CcSEcCtD
Tramadol—OPRM1—GPCR ligand binding—CCL5—atopic dermatitis	8.41e-05	0.00112	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—CCR3—atopic dermatitis	8.4e-05	0.00112	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—CXCL10—atopic dermatitis	8.39e-05	0.00112	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—CXCR3—atopic dermatitis	8.37e-05	0.00112	CbGpPWpGaD
Tramadol—Dyspepsia—Triamcinolone—atopic dermatitis	8.37e-05	0.000189	CcSEcCtD
Tramadol—Dyspepsia—Methylprednisolone—atopic dermatitis	8.35e-05	0.000189	CcSEcCtD
Tramadol—Hyperhidrosis—Betamethasone—atopic dermatitis	8.34e-05	0.000189	CcSEcCtD
Tramadol—Hyperhidrosis—Dexamethasone—atopic dermatitis	8.34e-05	0.000189	CcSEcCtD
Tramadol—Feeling abnormal—Hydrocortisone—atopic dermatitis	8.32e-05	0.000188	CcSEcCtD
Tramadol—Malaise—Prednisone—atopic dermatitis	8.3e-05	0.000188	CcSEcCtD
Tramadol—Vertigo—Prednisone—atopic dermatitis	8.27e-05	0.000187	CcSEcCtD
Tramadol—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	8.26e-05	0.000187	CcSEcCtD
Tramadol—Syncope—Prednisone—atopic dermatitis	8.25e-05	0.000187	CcSEcCtD
Tramadol—OPRK1—GPCR downstream signaling—TAC1—atopic dermatitis	8.24e-05	0.0011	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—NPS—atopic dermatitis	8.24e-05	0.0011	CbGpPWpGaD
Tramadol—Anorexia—Betamethasone—atopic dermatitis	8.22e-05	0.000186	CcSEcCtD
Tramadol—Anorexia—Dexamethasone—atopic dermatitis	8.22e-05	0.000186	CcSEcCtD
Tramadol—Urticaria—Prednisolone—atopic dermatitis	8.21e-05	0.000186	CcSEcCtD
Tramadol—Fatigue—Triamcinolone—atopic dermatitis	8.2e-05	0.000185	CcSEcCtD
Tramadol—Fatigue—Methylprednisolone—atopic dermatitis	8.18e-05	0.000185	CcSEcCtD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	8.16e-05	0.00109	CbGpPWpGaD
Tramadol—Pain—Triamcinolone—atopic dermatitis	8.13e-05	0.000184	CcSEcCtD
Tramadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	8.12e-05	0.00108	CbGpPWpGaD
Tramadol—Loss of consciousness—Prednisone—atopic dermatitis	8.09e-05	0.000183	CcSEcCtD
Tramadol—OPRK1—GPCR downstream signaling—CXCR3—atopic dermatitis	8.08e-05	0.00108	CbGpPWpGaD
Tramadol—Hypotension—Betamethasone—atopic dermatitis	8.06e-05	0.000182	CcSEcCtD
Tramadol—Hypotension—Dexamethasone—atopic dermatitis	8.06e-05	0.000182	CcSEcCtD
Tramadol—Urticaria—Hydrocortisone—atopic dermatitis	8.02e-05	0.000182	CcSEcCtD
Tramadol—CHRM3—Signaling by GPCR—CCL17—atopic dermatitis	7.98e-05	0.00106	CbGpPWpGaD
Tramadol—Body temperature increased—Hydrocortisone—atopic dermatitis	7.98e-05	0.000181	CcSEcCtD
Tramadol—Abdominal pain—Hydrocortisone—atopic dermatitis	7.98e-05	0.000181	CcSEcCtD
Tramadol—OPRM1—Signaling Pathways—CCL22—atopic dermatitis	7.98e-05	0.00106	CbGpPWpGaD
Tramadol—Convulsion—Prednisone—atopic dermatitis	7.97e-05	0.00018	CcSEcCtD
Tramadol—Hypertension—Prednisone—atopic dermatitis	7.95e-05	0.00018	CcSEcCtD
Tramadol—OPRD1—Signaling by GPCR—IL5—atopic dermatitis	7.93e-05	0.00106	CbGpPWpGaD
Tramadol—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	7.86e-05	0.000178	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	7.86e-05	0.000178	CcSEcCtD
Tramadol—Myalgia—Prednisone—atopic dermatitis	7.84e-05	0.000177	CcSEcCtD
Tramadol—Arthralgia—Prednisone—atopic dermatitis	7.84e-05	0.000177	CcSEcCtD
Tramadol—Feeling abnormal—Triamcinolone—atopic dermatitis	7.83e-05	0.000177	CcSEcCtD
Tramadol—Feeling abnormal—Methylprednisolone—atopic dermatitis	7.82e-05	0.000177	CcSEcCtD
Tramadol—OPRM1—GPCR downstream signaling—CCR3—atopic dermatitis	7.81e-05	0.00104	CbGpPWpGaD
Tramadol—Anxiety—Prednisone—atopic dermatitis	7.81e-05	0.000177	CcSEcCtD
Tramadol—Insomnia—Betamethasone—atopic dermatitis	7.8e-05	0.000177	CcSEcCtD
Tramadol—Insomnia—Dexamethasone—atopic dermatitis	7.8e-05	0.000177	CcSEcCtD
Tramadol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	7.78e-05	0.000176	CcSEcCtD
Tramadol—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	7.76e-05	0.000176	CcSEcCtD
Tramadol—Paraesthesia—Betamethasone—atopic dermatitis	7.74e-05	0.000175	CcSEcCtD
Tramadol—Paraesthesia—Dexamethasone—atopic dermatitis	7.74e-05	0.000175	CcSEcCtD
Tramadol—Discomfort—Prednisone—atopic dermatitis	7.74e-05	0.000175	CcSEcCtD
Tramadol—OPRD1—Signaling Pathways—KIF3A—atopic dermatitis	7.67e-05	0.00102	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—IL5—atopic dermatitis	7.66e-05	0.00102	CbGpPWpGaD
Tramadol—Hypersensitivity—Prednisolone—atopic dermatitis	7.62e-05	0.000172	CcSEcCtD
Tramadol—Dyspepsia—Betamethasone—atopic dermatitis	7.59e-05	0.000172	CcSEcCtD
Tramadol—Dyspepsia—Dexamethasone—atopic dermatitis	7.59e-05	0.000172	CcSEcCtD
Tramadol—OPRM1—GPCR ligand binding—CCR5—atopic dermatitis	7.58e-05	0.00101	CbGpPWpGaD
Tramadol—OPRM1—G alpha (i) signalling events—CXCL8—atopic dermatitis	7.56e-05	0.00101	CbGpPWpGaD
Tramadol—Urticaria—Triamcinolone—atopic dermatitis	7.55e-05	0.000171	CcSEcCtD
Tramadol—OPRK1—Signaling Pathways—CCL17—atopic dermatitis	7.55e-05	0.00101	CbGpPWpGaD
Tramadol—Urticaria—Methylprednisolone—atopic dermatitis	7.53e-05	0.000171	CcSEcCtD
Tramadol—Body temperature increased—Triamcinolone—atopic dermatitis	7.51e-05	0.00017	CcSEcCtD
Tramadol—Anaphylactic shock—Prednisone—atopic dermatitis	7.51e-05	0.00017	CcSEcCtD
Tramadol—Abdominal pain—Methylprednisolone—atopic dermatitis	7.5e-05	0.00017	CcSEcCtD
Tramadol—Decreased appetite—Dexamethasone—atopic dermatitis	7.5e-05	0.00017	CcSEcCtD
Tramadol—Decreased appetite—Betamethasone—atopic dermatitis	7.5e-05	0.00017	CcSEcCtD
Tramadol—OPRK1—Signaling by GPCR—TAC1—atopic dermatitis	7.48e-05	0.000998	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—NPS—atopic dermatitis	7.48e-05	0.000998	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CCL11—atopic dermatitis	7.47e-05	0.000997	CbGpPWpGaD
Tramadol—Infection—Prednisone—atopic dermatitis	7.46e-05	0.000169	CcSEcCtD
Tramadol—OPRD1—GPCR downstream signaling—CXCL10—atopic dermatitis	7.45e-05	0.000993	CbGpPWpGaD
Tramadol—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	7.45e-05	0.000169	CcSEcCtD
Tramadol—Gastrointestinal disorder—Betamethasone—atopic dermatitis	7.45e-05	0.000169	CcSEcCtD
Tramadol—Hypersensitivity—Hydrocortisone—atopic dermatitis	7.44e-05	0.000168	CcSEcCtD
Tramadol—Fatigue—Betamethasone—atopic dermatitis	7.44e-05	0.000168	CcSEcCtD
Tramadol—Fatigue—Dexamethasone—atopic dermatitis	7.44e-05	0.000168	CcSEcCtD
Tramadol—Shock—Prednisone—atopic dermatitis	7.39e-05	0.000167	CcSEcCtD
Tramadol—Pain—Dexamethasone—atopic dermatitis	7.38e-05	0.000167	CcSEcCtD
Tramadol—Pain—Betamethasone—atopic dermatitis	7.38e-05	0.000167	CcSEcCtD
Tramadol—HTR2C—Signaling Pathways—FCER2—atopic dermatitis	7.37e-05	0.000983	CbGpPWpGaD
Tramadol—Nervous system disorder—Prednisone—atopic dermatitis	7.37e-05	0.000167	CcSEcCtD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	7.36e-05	0.000981	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—CXCR3—atopic dermatitis	7.34e-05	0.000979	CbGpPWpGaD
Tramadol—Tachycardia—Prednisone—atopic dermatitis	7.33e-05	0.000166	CcSEcCtD
Tramadol—SLC6A4—SIDS Susceptibility Pathways—IL6—atopic dermatitis	7.31e-05	0.000974	CbGpPWpGaD
Tramadol—Skin disorder—Prednisone—atopic dermatitis	7.3e-05	0.000165	CcSEcCtD
Tramadol—Hyperhidrosis—Prednisone—atopic dermatitis	7.26e-05	0.000164	CcSEcCtD
Tramadol—Asthenia—Hydrocortisone—atopic dermatitis	7.24e-05	0.000164	CcSEcCtD
Tramadol—CHRM3—GPCR ligand binding—CXCL10—atopic dermatitis	7.22e-05	0.000963	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—CCL5—atopic dermatitis	7.22e-05	0.000963	CbGpPWpGaD
Tramadol—Anorexia—Prednisone—atopic dermatitis	7.16e-05	0.000162	CcSEcCtD
Tramadol—Pruritus—Hydrocortisone—atopic dermatitis	7.14e-05	0.000162	CcSEcCtD
Tramadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	7.12e-05	0.000949	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCL27—atopic dermatitis	7.11e-05	0.000948	CbGpPWpGaD
Tramadol—Feeling abnormal—Betamethasone—atopic dermatitis	7.11e-05	0.000161	CcSEcCtD
Tramadol—Feeling abnormal—Dexamethasone—atopic dermatitis	7.11e-05	0.000161	CcSEcCtD
Tramadol—OPRM1—Signaling by GPCR—CCR3—atopic dermatitis	7.1e-05	0.000946	CbGpPWpGaD
Tramadol—Gastrointestinal pain—Betamethasone—atopic dermatitis	7.05e-05	0.00016	CcSEcCtD
Tramadol—Gastrointestinal pain—Dexamethasone—atopic dermatitis	7.05e-05	0.00016	CcSEcCtD
Tramadol—Hypersensitivity—Triamcinolone—atopic dermatitis	7e-05	0.000159	CcSEcCtD
Tramadol—Hypersensitivity—Methylprednisolone—atopic dermatitis	6.99e-05	0.000158	CcSEcCtD
Tramadol—OPRM1—GPCR downstream signaling—TAC1—atopic dermatitis	6.96e-05	0.000929	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—NPS—atopic dermatitis	6.96e-05	0.000929	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—IL5—atopic dermatitis	6.96e-05	0.000928	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CMA1—atopic dermatitis	6.94e-05	0.000925	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CCL11—atopic dermatitis	6.94e-05	0.000925	CbGpPWpGaD
Tramadol—Diarrhoea—Hydrocortisone—atopic dermatitis	6.91e-05	0.000156	CcSEcCtD
Tramadol—HTR2C—Signaling Pathways—CCL22—atopic dermatitis	6.85e-05	0.000914	CbGpPWpGaD
Tramadol—Urticaria—Dexamethasone—atopic dermatitis	6.85e-05	0.000155	CcSEcCtD
Tramadol—Urticaria—Betamethasone—atopic dermatitis	6.85e-05	0.000155	CcSEcCtD
Tramadol—Musculoskeletal discomfort—Prednisone—atopic dermatitis	6.84e-05	0.000155	CcSEcCtD
Tramadol—Dizziness—Prednisolone—atopic dermatitis	6.84e-05	0.000155	CcSEcCtD
Tramadol—OPRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	6.83e-05	0.000911	CbGpPWpGaD
Tramadol—Asthenia—Triamcinolone—atopic dermatitis	6.82e-05	0.000154	CcSEcCtD
Tramadol—Body temperature increased—Betamethasone—atopic dermatitis	6.82e-05	0.000154	CcSEcCtD
Tramadol—Abdominal pain—Dexamethasone—atopic dermatitis	6.82e-05	0.000154	CcSEcCtD
Tramadol—Abdominal pain—Betamethasone—atopic dermatitis	6.82e-05	0.000154	CcSEcCtD
Tramadol—Body temperature increased—Dexamethasone—atopic dermatitis	6.82e-05	0.000154	CcSEcCtD
Tramadol—Asthenia—Methylprednisolone—atopic dermatitis	6.8e-05	0.000154	CcSEcCtD
Tramadol—Insomnia—Prednisone—atopic dermatitis	6.79e-05	0.000154	CcSEcCtD
Tramadol—OPRD1—Signaling by GPCR—CXCL10—atopic dermatitis	6.76e-05	0.000902	CbGpPWpGaD
Tramadol—Paraesthesia—Prednisone—atopic dermatitis	6.74e-05	0.000153	CcSEcCtD
Tramadol—OPRK1—Signaling Pathways—KIF3A—atopic dermatitis	6.73e-05	0.000897	CbGpPWpGaD
Tramadol—Pruritus—Triamcinolone—atopic dermatitis	6.73e-05	0.000152	CcSEcCtD
Tramadol—Pruritus—Methylprednisolone—atopic dermatitis	6.71e-05	0.000152	CcSEcCtD
Tramadol—HTR2C—GPCR downstream signaling—CCR3—atopic dermatitis	6.71e-05	0.000895	CbGpPWpGaD
Tramadol—Dizziness—Hydrocortisone—atopic dermatitis	6.68e-05	0.000151	CcSEcCtD
Tramadol—Dyspepsia—Prednisone—atopic dermatitis	6.61e-05	0.00015	CcSEcCtD
Tramadol—OPRK1—GPCR downstream signaling—CXCL10—atopic dermatitis	6.53e-05	0.000871	CbGpPWpGaD
Tramadol—Decreased appetite—Prednisone—atopic dermatitis	6.53e-05	0.000148	CcSEcCtD
Tramadol—OPRD1—Signaling Pathways—STAT6—atopic dermatitis	6.52e-05	0.00087	CbGpPWpGaD
Tramadol—Rash—Prednisolone—atopic dermatitis	6.52e-05	0.000148	CcSEcCtD
Tramadol—Dermatitis—Prednisolone—atopic dermatitis	6.51e-05	0.000147	CcSEcCtD
Tramadol—HTR2C—GPCR ligand binding—CCR5—atopic dermatitis	6.51e-05	0.000868	CbGpPWpGaD
Tramadol—Diarrhoea—Methylprednisolone—atopic dermatitis	6.49e-05	0.000147	CcSEcCtD
Tramadol—Fatigue—Prednisone—atopic dermatitis	6.48e-05	0.000147	CcSEcCtD
Tramadol—Headache—Prednisolone—atopic dermatitis	6.48e-05	0.000147	CcSEcCtD
Tramadol—OPRM1—GPCR downstream signaling—IL5—atopic dermatitis	6.47e-05	0.000863	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CCL11—atopic dermatitis	6.44e-05	0.000858	CbGpPWpGaD
Tramadol—Constipation—Prednisone—atopic dermatitis	6.42e-05	0.000145	CcSEcCtD
Tramadol—Vomiting—Hydrocortisone—atopic dermatitis	6.42e-05	0.000145	CcSEcCtD
Tramadol—OPRD1—GPCR downstream signaling—CCL5—atopic dermatitis	6.41e-05	0.000855	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCL17—atopic dermatitis	6.38e-05	0.000851	CbGpPWpGaD
Tramadol—Rash—Hydrocortisone—atopic dermatitis	6.37e-05	0.000144	CcSEcCtD
Tramadol—Dermatitis—Hydrocortisone—atopic dermatitis	6.36e-05	0.000144	CcSEcCtD
Tramadol—CHRM3—Signaling Pathways—FCER2—atopic dermatitis	6.35e-05	0.000846	CbGpPWpGaD
Tramadol—Headache—Hydrocortisone—atopic dermatitis	6.32e-05	0.000143	CcSEcCtD
Tramadol—OPRM1—Signaling by GPCR—TAC1—atopic dermatitis	6.32e-05	0.000843	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—NPS—atopic dermatitis	6.32e-05	0.000843	CbGpPWpGaD
Tramadol—Dizziness—Triamcinolone—atopic dermatitis	6.29e-05	0.000142	CcSEcCtD
Tramadol—Dizziness—Methylprednisolone—atopic dermatitis	6.27e-05	0.000142	CcSEcCtD
Tramadol—CHRM3—GPCR ligand binding—CCL5—atopic dermatitis	6.22e-05	0.000829	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—CXCR3—atopic dermatitis	6.2e-05	0.000827	CbGpPWpGaD
Tramadol—Feeling abnormal—Prednisone—atopic dermatitis	6.19e-05	0.00014	CcSEcCtD
Tramadol—Asthenia—Dexamethasone—atopic dermatitis	6.19e-05	0.00014	CcSEcCtD
Tramadol—Asthenia—Betamethasone—atopic dermatitis	6.19e-05	0.00014	CcSEcCtD
Tramadol—OPRD1—GPCR ligand binding—CXCL8—atopic dermatitis	6.18e-05	0.000824	CbGpPWpGaD
Tramadol—Gastrointestinal pain—Prednisone—atopic dermatitis	6.14e-05	0.000139	CcSEcCtD
Tramadol—Nausea—Prednisolone—atopic dermatitis	6.14e-05	0.000139	CcSEcCtD
Tramadol—HTR2C—Signaling Pathways—CCL27—atopic dermatitis	6.11e-05	0.000814	CbGpPWpGaD
Tramadol—Pruritus—Betamethasone—atopic dermatitis	6.1e-05	0.000138	CcSEcCtD
Tramadol—Pruritus—Dexamethasone—atopic dermatitis	6.1e-05	0.000138	CcSEcCtD
Tramadol—HTR2C—Signaling by GPCR—CCR3—atopic dermatitis	6.09e-05	0.000813	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CCL11—atopic dermatitis	6.08e-05	0.000811	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CMA1—atopic dermatitis	6.08e-05	0.000811	CbGpPWpGaD
Tramadol—Vomiting—Triamcinolone—atopic dermatitis	6.04e-05	0.000137	CcSEcCtD
Tramadol—Vomiting—Methylprednisolone—atopic dermatitis	6.03e-05	0.000136	CcSEcCtD
Tramadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	6.01e-05	0.000802	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—GLB1—atopic dermatitis	6e-05	0.0008	CbGpPWpGaD
Tramadol—Nausea—Hydrocortisone—atopic dermatitis	6e-05	0.000136	CcSEcCtD
Tramadol—Rash—Triamcinolone—atopic dermatitis	5.99e-05	0.000136	CcSEcCtD
Tramadol—SLC6A2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	5.99e-05	0.000799	CbGpPWpGaD
Tramadol—Dermatitis—Triamcinolone—atopic dermatitis	5.99e-05	0.000136	CcSEcCtD
Tramadol—HTR2C—GPCR downstream signaling—TAC1—atopic dermatitis	5.98e-05	0.000798	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—NPS—atopic dermatitis	5.98e-05	0.000798	CbGpPWpGaD
Tramadol—Rash—Methylprednisolone—atopic dermatitis	5.98e-05	0.000135	CcSEcCtD
Tramadol—Dermatitis—Methylprednisolone—atopic dermatitis	5.97e-05	0.000135	CcSEcCtD
Tramadol—Urticaria—Prednisone—atopic dermatitis	5.97e-05	0.000135	CcSEcCtD
Tramadol—SLC6A4—Circadian rythm related genes—IL6—atopic dermatitis	5.97e-05	0.000796	CbGpPWpGaD
Tramadol—Headache—Triamcinolone—atopic dermatitis	5.96e-05	0.000135	CcSEcCtD
Tramadol—Headache—Methylprednisolone—atopic dermatitis	5.94e-05	0.000134	CcSEcCtD
Tramadol—Abdominal pain—Prednisone—atopic dermatitis	5.94e-05	0.000134	CcSEcCtD
Tramadol—Body temperature increased—Prednisone—atopic dermatitis	5.94e-05	0.000134	CcSEcCtD
Tramadol—OPRK1—Signaling by GPCR—CXCL10—atopic dermatitis	5.93e-05	0.000791	CbGpPWpGaD
Tramadol—Diarrhoea—Betamethasone—atopic dermatitis	5.9e-05	0.000134	CcSEcCtD
Tramadol—Diarrhoea—Dexamethasone—atopic dermatitis	5.9e-05	0.000134	CcSEcCtD
Tramadol—CHRM3—Signaling Pathways—CCL22—atopic dermatitis	5.9e-05	0.000787	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—IL5—atopic dermatitis	5.88e-05	0.000784	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—CXCR3—atopic dermatitis	5.86e-05	0.000782	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—CCL5—atopic dermatitis	5.82e-05	0.000777	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—CCR5—atopic dermatitis	5.78e-05	0.00077	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CCR3—atopic dermatitis	5.78e-05	0.00077	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—ADSL—atopic dermatitis	5.75e-05	0.000767	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—STAT6—atopic dermatitis	5.72e-05	0.000763	CbGpPWpGaD
Tramadol—Dizziness—Betamethasone—atopic dermatitis	5.7e-05	0.000129	CcSEcCtD
Tramadol—Dizziness—Dexamethasone—atopic dermatitis	5.7e-05	0.000129	CcSEcCtD
Tramadol—OPRM1—Signaling Pathways—KIF3A—atopic dermatitis	5.69e-05	0.000758	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CCR3—atopic dermatitis	5.66e-05	0.000754	CbGpPWpGaD
Tramadol—Nausea—Triamcinolone—atopic dermatitis	5.65e-05	0.000128	CcSEcCtD
Tramadol—Nausea—Methylprednisolone—atopic dermatitis	5.63e-05	0.000128	CcSEcCtD
Tramadol—OPRK1—GPCR downstream signaling—CCL5—atopic dermatitis	5.62e-05	0.00075	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—CCR5—atopic dermatitis	5.6e-05	0.000747	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—IL5—atopic dermatitis	5.56e-05	0.000741	CbGpPWpGaD
Tramadol—Hypersensitivity—Prednisone—atopic dermatitis	5.53e-05	0.000125	CcSEcCtD
Tramadol—OPRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	5.52e-05	0.000736	CbGpPWpGaD
Tramadol—Vomiting—Betamethasone—atopic dermatitis	5.48e-05	0.000124	CcSEcCtD
Tramadol—Vomiting—Dexamethasone—atopic dermatitis	5.48e-05	0.000124	CcSEcCtD
Tramadol—HTR2C—Signaling Pathways—CCL17—atopic dermatitis	5.48e-05	0.000731	CbGpPWpGaD
Tramadol—Rash—Betamethasone—atopic dermatitis	5.44e-05	0.000123	CcSEcCtD
Tramadol—Rash—Dexamethasone—atopic dermatitis	5.44e-05	0.000123	CcSEcCtD
Tramadol—Dermatitis—Betamethasone—atopic dermatitis	5.43e-05	0.000123	CcSEcCtD
Tramadol—Dermatitis—Dexamethasone—atopic dermatitis	5.43e-05	0.000123	CcSEcCtD
Tramadol—HTR2C—Signaling by GPCR—TAC1—atopic dermatitis	5.43e-05	0.000724	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—NPS—atopic dermatitis	5.43e-05	0.000724	CbGpPWpGaD
Tramadol—OPRK1—GPCR ligand binding—CXCL8—atopic dermatitis	5.42e-05	0.000723	CbGpPWpGaD
Tramadol—Headache—Dexamethasone—atopic dermatitis	5.4e-05	0.000122	CcSEcCtD
Tramadol—Headache—Betamethasone—atopic dermatitis	5.4e-05	0.000122	CcSEcCtD
Tramadol—Asthenia—Prednisone—atopic dermatitis	5.39e-05	0.000122	CcSEcCtD
Tramadol—HTR2C—Signaling by GPCR—CXCR3—atopic dermatitis	5.33e-05	0.00071	CbGpPWpGaD
Tramadol—Pruritus—Prednisone—atopic dermatitis	5.31e-05	0.00012	CcSEcCtD
Tramadol—CHRM3—Signaling Pathways—CCL27—atopic dermatitis	5.26e-05	0.000701	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CCR3—atopic dermatitis	5.25e-05	0.0007	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—CCR5—atopic dermatitis	5.25e-05	0.0007	CbGpPWpGaD
Tramadol—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	5.16e-05	0.000689	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—GLB1—atopic dermatitis	5.16e-05	0.000688	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—TAC1—atopic dermatitis	5.15e-05	0.000687	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—NPS—atopic dermatitis	5.15e-05	0.000687	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCL11—atopic dermatitis	5.14e-05	0.000686	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CMA1—atopic dermatitis	5.14e-05	0.000686	CbGpPWpGaD
Tramadol—Diarrhoea—Prednisone—atopic dermatitis	5.14e-05	0.000116	CcSEcCtD
Tramadol—Nausea—Dexamethasone—atopic dermatitis	5.12e-05	0.000116	CcSEcCtD
Tramadol—Nausea—Betamethasone—atopic dermatitis	5.12e-05	0.000116	CcSEcCtD
Tramadol—OPRK1—Signaling by GPCR—CCL5—atopic dermatitis	5.11e-05	0.000681	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—CCR5—atopic dermatitis	5.07e-05	0.000676	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CXCR3—atopic dermatitis	5.05e-05	0.000673	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—IL5—atopic dermatitis	5.05e-05	0.000673	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—TAC1—atopic dermatitis	5.04e-05	0.000672	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NPS—atopic dermatitis	5.04e-05	0.000672	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—CXCL10—atopic dermatitis	5.01e-05	0.000669	CbGpPWpGaD
Tramadol—Dizziness—Prednisone—atopic dermatitis	4.97e-05	0.000112	CcSEcCtD
Tramadol—OPRK1—Signaling Pathways—CCR3—atopic dermatitis	4.96e-05	0.000661	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—ADSL—atopic dermatitis	4.95e-05	0.00066	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CXCR3—atopic dermatitis	4.94e-05	0.000659	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—KIF3A—atopic dermatitis	4.88e-05	0.000651	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—STAT6—atopic dermatitis	4.83e-05	0.000645	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—IL5—atopic dermatitis	4.79e-05	0.000638	CbGpPWpGaD
Tramadol—Vomiting—Prednisone—atopic dermatitis	4.78e-05	0.000108	CcSEcCtD
Tramadol—OPRM1—GPCR downstream signaling—CCL5—atopic dermatitis	4.75e-05	0.000634	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—CXCL10—atopic dermatitis	4.74e-05	0.000632	CbGpPWpGaD
Tramadol—Rash—Prednisone—atopic dermatitis	4.74e-05	0.000107	CcSEcCtD
Tramadol—Dermatitis—Prednisone—atopic dermatitis	4.73e-05	0.000107	CcSEcCtD
Tramadol—CHRM3—Signaling Pathways—CCL17—atopic dermatitis	4.72e-05	0.000629	CbGpPWpGaD
Tramadol—Headache—Prednisone—atopic dermatitis	4.71e-05	0.000107	CcSEcCtD
Tramadol—OPRD1—Signaling Pathways—IL5—atopic dermatitis	4.69e-05	0.000625	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—TAC1—atopic dermatitis	4.68e-05	0.000624	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—NPS—atopic dermatitis	4.68e-05	0.000624	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—CCR5—atopic dermatitis	4.6e-05	0.000613	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CXCR3—atopic dermatitis	4.59e-05	0.000612	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—CXCL8—atopic dermatitis	4.58e-05	0.000611	CbGpPWpGaD
Tramadol—Nausea—Prednisone—atopic dermatitis	4.46e-05	0.000101	CcSEcCtD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	4.45e-05	0.000593	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NPS—atopic dermatitis	4.42e-05	0.00059	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—TAC1—atopic dermatitis	4.42e-05	0.00059	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CMA1—atopic dermatitis	4.42e-05	0.000589	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCL11—atopic dermatitis	4.42e-05	0.000589	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL5—atopic dermatitis	4.35e-05	0.00058	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CXCR3—atopic dermatitis	4.33e-05	0.000578	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—CCL5—atopic dermatitis	4.32e-05	0.000575	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CXCL10—atopic dermatitis	4.3e-05	0.000574	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—CCR5—atopic dermatitis	4.28e-05	0.000571	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—KIF3A—atopic dermatitis	4.2e-05	0.000561	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCR3—atopic dermatitis	4.19e-05	0.000559	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—STAT6—atopic dermatitis	4.15e-05	0.000554	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL5—atopic dermatitis	4.11e-05	0.000548	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CXCL10—atopic dermatitis	4.08e-05	0.000544	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—CCL5—atopic dermatitis	4.08e-05	0.000544	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CXCL10—atopic dermatitis	4e-05	0.000533	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—CXCL8—atopic dermatitis	3.93e-05	0.000525	CbGpPWpGaD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	3.92e-05	0.000523	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—CCR5—atopic dermatitis	3.89e-05	0.000518	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCL11—atopic dermatitis	3.8e-05	0.000507	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CMA1—atopic dermatitis	3.8e-05	0.000507	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—TAC1—atopic dermatitis	3.74e-05	0.000498	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NPS—atopic dermatitis	3.74e-05	0.000498	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CXCL10—atopic dermatitis	3.71e-05	0.000494	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CCL5—atopic dermatitis	3.71e-05	0.000494	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—CCR5—atopic dermatitis	3.68e-05	0.00049	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CXCR3—atopic dermatitis	3.66e-05	0.000489	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCR3—atopic dermatitis	3.6e-05	0.00048	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—GLB1—atopic dermatitis	3.59e-05	0.000478	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—STAT6—atopic dermatitis	3.57e-05	0.000477	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CCL5—atopic dermatitis	3.51e-05	0.000469	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CXCL10—atopic dermatitis	3.5e-05	0.000467	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	3.49e-05	0.000466	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL5—atopic dermatitis	3.47e-05	0.000463	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CCL5—atopic dermatitis	3.44e-05	0.000459	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—ADSL—atopic dermatitis	3.44e-05	0.000459	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—CXCL8—atopic dermatitis	3.39e-05	0.000452	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	3.37e-05	0.00045	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CCR5—atopic dermatitis	3.34e-05	0.000445	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—IL2—atopic dermatitis	3.34e-05	0.000445	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—TAC1—atopic dermatitis	3.21e-05	0.000428	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NPS—atopic dermatitis	3.21e-05	0.000428	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CCL5—atopic dermatitis	3.19e-05	0.000425	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NGF—atopic dermatitis	3.19e-05	0.000425	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—CXCL8—atopic dermatitis	3.17e-05	0.000423	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CCR5—atopic dermatitis	3.17e-05	0.000422	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CXCR3—atopic dermatitis	3.15e-05	0.00042	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CCR5—atopic dermatitis	3.1e-05	0.000413	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCR3—atopic dermatitis	3.1e-05	0.000413	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—CXCL8—atopic dermatitis	3.06e-05	0.000408	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—IL2—atopic dermatitis	3.03e-05	0.000404	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CCL5—atopic dermatitis	3.02e-05	0.000402	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL5—atopic dermatitis	2.98e-05	0.000398	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CXCL10—atopic dermatitis	2.96e-05	0.000395	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—IL2—atopic dermatitis	2.93e-05	0.00039	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CCR5—atopic dermatitis	2.87e-05	0.000383	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NGF—atopic dermatitis	2.79e-05	0.000373	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—CXCL8—atopic dermatitis	2.78e-05	0.000371	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NPS—atopic dermatitis	2.76e-05	0.000368	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—TAC1—atopic dermatitis	2.76e-05	0.000368	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CCR5—atopic dermatitis	2.72e-05	0.000362	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CXCR3—atopic dermatitis	2.71e-05	0.000361	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—IL2—atopic dermatitis	2.66e-05	0.000354	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—NFKBIA—atopic dermatitis	2.63e-05	0.00035	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	2.59e-05	0.000345	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL5—atopic dermatitis	2.57e-05	0.000342	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCL5—atopic dermatitis	2.55e-05	0.00034	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CXCL10—atopic dermatitis	2.54e-05	0.000339	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—IL2—atopic dermatitis	2.47e-05	0.00033	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NGF—atopic dermatitis	2.36e-05	0.000315	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—CXCL8—atopic dermatitis	2.35e-05	0.000313	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—GLB1—atopic dermatitis	2.35e-05	0.000313	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—NFKBIA—atopic dermatitis	2.3e-05	0.000307	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CCR5—atopic dermatitis	2.3e-05	0.000306	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—ADSL—atopic dermatitis	2.25e-05	0.0003	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—IL2—atopic dermatitis	2.25e-05	0.0003	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—CXCL8—atopic dermatitis	2.22e-05	0.000296	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CXCL10—atopic dermatitis	2.19e-05	0.000292	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCL5—atopic dermatitis	2.19e-05	0.000292	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—IL2—atopic dermatitis	2.12e-05	0.000283	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NGF—atopic dermatitis	2.03e-05	0.00027	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CXCL8—atopic dermatitis	2.02e-05	0.000269	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CCR5—atopic dermatitis	1.97e-05	0.000263	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—NFKBIA—atopic dermatitis	1.95e-05	0.00026	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—PPARA—atopic dermatitis	1.95e-05	0.00026	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—IL2—atopic dermatitis	1.93e-05	0.000257	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CXCL8—atopic dermatitis	1.91e-05	0.000255	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCL5—atopic dermatitis	1.88e-05	0.000251	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CXCL8—atopic dermatitis	1.87e-05	0.00025	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—IL2—atopic dermatitis	1.83e-05	0.000244	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IL2—atopic dermatitis	1.79e-05	0.000239	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—IL6—atopic dermatitis	1.78e-05	0.000238	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NGF—atopic dermatitis	1.75e-05	0.000233	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CXCL8—atopic dermatitis	1.74e-05	0.000232	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CCR5—atopic dermatitis	1.7e-05	0.000226	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—PPARA—atopic dermatitis	1.67e-05	0.000223	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—NFKBIA—atopic dermatitis	1.67e-05	0.000223	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL2—atopic dermatitis	1.66e-05	0.000221	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—MAPK8—atopic dermatitis	1.65e-05	0.00022	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CXCL8—atopic dermatitis	1.64e-05	0.000219	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL2—atopic dermatitis	1.57e-05	0.000209	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—IL6—atopic dermatitis	1.56e-05	0.000208	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—MAPK8—atopic dermatitis	1.45e-05	0.000193	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—NFKBIA—atopic dermatitis	1.44e-05	0.000192	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CXCL8—atopic dermatitis	1.39e-05	0.000185	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL2—atopic dermatitis	1.33e-05	0.000177	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—IL6—atopic dermatitis	1.32e-05	0.000176	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—MAPK8—atopic dermatitis	1.22e-05	0.000163	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CXCL8—atopic dermatitis	1.19e-05	0.000159	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—PPARA—atopic dermatitis	1.16e-05	0.000155	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL2—atopic dermatitis	1.14e-05	0.000152	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—IL6—atopic dermatitis	1.13e-05	0.000151	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—IL6—atopic dermatitis	1.05e-05	0.00014	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—MAPK8—atopic dermatitis	1.05e-05	0.00014	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CXCL8—atopic dermatitis	1.03e-05	0.000137	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL2—atopic dermatitis	9.81e-06	0.000131	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—IL6—atopic dermatitis	9.76e-06	0.00013	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—IL6—atopic dermatitis	9.23e-06	0.000123	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—MAPK8—atopic dermatitis	9.03e-06	0.00012	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—IL6—atopic dermatitis	7.8e-06	0.000104	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—PPARA—atopic dermatitis	7.61e-06	0.000101	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—IL6—atopic dermatitis	6.7e-06	8.93e-05	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—IL6—atopic dermatitis	5.77e-06	7.69e-05	CbGpPWpGaD
